Premium
Analysis of ABO chimera from peripheral red cells and reticulocytes by flow cytometry and micro gel column technique in patients post‐ ABO ‐incompatible HSCT
Author(s) -
Chen Jianhua,
Liu Feng
Publication year - 2018
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13175
Subject(s) - abo blood group system , chimera (genetics) , flow cytometry , medicine , immunology , biology , biochemistry , gene
Background How to choose an appropriate method to monitoring dynamic ABO chimera post‐ ABO ‐incompatible HSCT is crucial to not only assess the status of erythroid engraftment but also achieve personalized safety transfusion. Methods We evaluated the efficacy of micro gel column technique ( MGCT ) and flow cytometry ( FCM ) by series of artificial ABO chimera mixtures from 0.5% to 50% and by investigating 15 cases of ABO ‐incompatible HSCT patients with longitudinally ABO blood grouping and ABO chimera from RBC s and reticulocytes. Results 5% and 2% of ABO chimera mixtures can be efficiently detected by MGCT and FCM , respectively. 6.3% of donor RBC s with 44.77% of donor reticulocytes in the early phase and 7.9% of patient RBC s with 96% of donor reticulocytes in the phase of complete donor type can be detected by FCM rather than failure by MGCT simultaneously. However, in case 8#, 8.6% of donor reticulocytes rather than 99.1% of donor RBC s on the 98th day post‐ HSCT could adequately predict early relapse. Conclusions Investigation of ABO chimera from reticulocytes by FCM is a more effective strategy rather than ABO blood grouping and RBC s by FCM to indicate the true progress of erythroid alteration and achieve personalized safety transfusion post‐ ABO ‐incompatible HSCT .